ROELMI LIFE SCIENCE s.r.l. – Trademark Portfolio
Entity Type: 98
ROELMI LIFE SCIENCE s.r.l. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SINO VITAL and SINO LIFESCIENCE.
Via Celeste Milani 24
I-21040 Origgio (VA)
Showing of trademarks Trademarks
Trademark Classifications
ROELMI LIFE SCIENCE s.r.l.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ROELMI LIFE SCIENCE s.r.l. have?
ROELMI LIFE SCIENCE s.r.l. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does ROELMI LIFE SCIENCE s.r.l. file in?
ROELMI LIFE SCIENCE s.r.l. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are ROELMI LIFE SCIENCE s.r.l.'s most well-known trademarks?
ROELMI LIFE SCIENCE s.r.l.'s registered trademark portfolio includes well-known marks such as SINO VITAL and SINO LIFESCIENCE. These are among 2 currently registered trademarks in the portfolio.
What is ROELMI LIFE SCIENCE s.r.l.'s trademark registration success rate?
ROELMI LIFE SCIENCE s.r.l. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.